In this category, we have collected articles related to experimental methods and other aspects of our services from the News & Learning Center categories. Some articles provide an in-depth look at experimental methods, while others show examples of their use, such as the benefits of NMR spectroscopy in biosimilars comparability studies, the technique of weak-affinity chromatography and its applications, and crystallographic fragment screening and room-temperature crystallography at synchrotrons. A couple of articles highlight the importance of contract research organizations (CROs) in reducing costs and speeding up the drug discovery process. We hope you enjoy reading!
Technical developments have made crystallographic fragment screening the most effective method for screening fragment libraries. Here, we provide a brief overview of the method and its requirements.
We discuss the the early drug discovery services market and highlight the integrated drug discovery CRO services provided by SARomics Biostructures.
SARomics Biostructures AB and Vipergen ApS partner to offer hit and lead identification services based on Vipergen’s unique DNA-encoded library (DEL) screening technology.
In the this article we discuss evidence that shows that NMR spectroscopy is far superior to other established methods for biosimilar’s higher order structure analysis.
In this article, we discuss weak affinity chromatography (WAC™), the proprietary fragment screening technique jointly owned by SARomics Biostructures and Red Glead Discovery.
After many years of cryo-crystallography dominance, room-temperature X-ray crystallography using synchrotron radiation has returned. We discuss the application of room-temperature X-ray crystallography in drug design.
In this post, we discuss therapeutic antibodies and biosimilars and the need for biosimilar comparability analysis and characterization, with a focus on methods for assessing structural comparability.
What makes a successful services company? What is our strength, and how to define our selling points? We arrive at a list of 8 essential selling points defining the success of SARomics Biostructures.
In this third post on structural biology and structure-based drug design we discuss methods and benefits of fragment-based lead discovery